bioAffinity Technologies (BIAF) Change in Account Payables (2021 - 2026)
bioAffinity Technologies (BIAF) posted quarterly Change in Account Payables of $74310.0 for Q1 2026, down 81.15% YoY from $394267.0 in Q1 2025, and up 141.55% sequentially from -$178860.0 in Q4 2025.
bioAffinity Technologies (BIAF) Change in Account Payables (2021 - 2026) Analysis & Trends
bioAffinity Technologies has disclosed Change in Account Payables across 6 years of filings, most recently posting $74310.0 for Q1 2026.
- In Q1 2026, Change in Account Payables fell 81.15% year-over-year to $74310.0; the TTM figure through Mar 2026 stood at -$545367.0 (down 154.67% YoY), while the FY2025 annual figure was -$225410.0, down 158.93% from the prior year.
- Change in Account Payables improved to $74310.0 in Q1 2026, from -$178860.0 in the prior quarter.
- Over the last five years, Change in Account Payables for BIAF reached as high as $577474.0 in Q3 2023 and fell as low as -$435285.0 in Q3 2022.
- The 5-year median for Change in Account Payables is $17284.0 (2022), against an average of $19503.2.
- Annual changes were most pronounced in 2023 — Change in Account Payables slumped 1248.49% — and 2024, when it surged 1565.44%.
- A 5-year view of Change in Account Payables shows it stood at $195360.0 in 2022, then slumped by 315.67% to -$421337.0 in 2023, then jumped by 148.51% to $204373.0 in 2024, then slumped by 187.52% to -$178860.0 in 2025, then jumped by 141.55% to $74310.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $74310.0, -$178860.0, and -$229076.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -41.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 11.22 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 21.88 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 15.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -12.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -38.09 Mn |
| 10 | bioAffinity Technologies | 3.78 Mn | 675,591.56 | - | 74,310.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 74,310.00 |
| Mar 31, 2026 | 74,310.00 |
| Dec 31, 2025 | -178,860.00 |
| Dec 31, 2025 | -178,860.00 |
| Sep 30, 2025 | -229,076.00 |
| Sep 30, 2025 | -229,076.00 |
| Jun 30, 2025 | -211,741.00 |
| Jun 30, 2025 | -211,741.00 |
| Mar 31, 2025 | 394,267.00 |
| Mar 31, 2025 | 394,267.00 |
| Dec 31, 2024 | 204,373.00 |
| Dec 31, 2024 | 204,373.00 |
| Sep 30, 2024 | -65,165.00 |
| Sep 30, 2024 | -65,165.00 |
| Jun 30, 2024 | 464,109.00 |
| Jun 30, 2024 | 464,109.00 |
| Mar 31, 2024 | -220,796.00 |
| Mar 31, 2024 | -220,796.00 |
| Dec 31, 2023 | -421,337.00 |
| Dec 31, 2023 | -421,337.00 |